Published • loading... • Updated
Ozempic boom collides with America's eating habits as restaurants shrink portions
Study of 293 GLP-1 receptor agonist initiators showed reduced purchases of sugar, saturated fat, and ultraprocessed foods, with increased protein, based on 1.98 million supermarket receipts.
Summary by Ground News
5 Articles
5 Articles
McKee’s proposed FY2027 budget drops GLP-1 drugs for weight loss from Medicaid
Ozempic is the most well-known of drug class known as GLP-1 receptor agonists, which are prescribed for treating Type 2 diabetes and obesity. Ozempic is indicated for diabetes but was widely prescribed off-label for weight loss before the emergence of alternative drugs. (Product image courtesy of Novo Nordisk; Photo illustration by Alexander Castro/Rhode Island Current)Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item …
Doctors repeat this mantra: "If there is no change in diet and in the level of physical activity, these drugs do not work to cope with obesity."...
·Madrid, Spain
Read Full ArticleCoverage Details
Total News Sources5
Leaning Left1Leaning Right2Center0Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
L 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium


